Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul;14(1):993-998.
doi: 10.3892/ol.2017.6206. Epub 2017 May 19.

Dermatofibrosarcoma protuberans of the breast: A case report

Affiliations

Dermatofibrosarcoma protuberans of the breast: A case report

Kamil Pohlodek et al. Oncol Lett. 2017 Jul.

Abstract

Dermatofibrosarcoma protuberans (DFSP) is a rare malignant tumor of subcutaneous tissue characterized by slow infiltrative growth. The tumor occurs in patients of all ages, with the highest frequency occurring between the second and the fifth decades of age. Genetically, DFSP is characterized by a reciprocal translocation t(17;22)(q22;q13), or more often, as a supernumerary ring chromosome involving chromosomes 17 and 22. Standard treatment of a localized tumor is surgical excision with wide margins. In the present study, a case report of a 43-year-old woman with a growing tumor in the left breast is discussed. The patient underwent breast-conserving surgery. Histological and cytogenetic examinations of the tumor resulted in a diagnosis of DFSP. The clinical and morphological characteristics of the tumor, in addition to the treatment options, were also evaluated.

Keywords: breast tumor; dermatofibrosarcoma protuberans.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Dematofibrosarcoma protuberans of the breast. (A) A circumscribed round, partially lobulated radiopaque lesion with sharp contour was revealed following an X-ray digital mammography of the left breast. (B) A round tumor protruded above the surface of the skin in the medial quadrants of the left breast. (C) Gross examination revealed a 12.0×9.0×8.0-cm segment of breast tissue with a circumscribed 6.2×6.2×5.0-cm tumor, which was tan-grey colored on the cut surface.
Figure 2.
Figure 2.
Hematoxylin-eosin staining of tissue from a patient with dermatofibrosarcoma protuberans of the breast. (A) Tumor growth into the skin demonstrated a zone of uninvolved dermis with chronic inflammatory infiltrate and spindle cell proliferation adjacent to the overlying epidermis (magnification, ×100). (B) Tentacles of tumor surround the residual structures of the mammary glands (magnification, ×200). (C) Highly cellular and tight storiform patterning of cells that are monomorphic, thin, and spindly with hyperchromatic nuclei (magnification, ×200). (D) Mitotic figure without atypical mitoses (magnification, ×400).
Figure 3.
Figure 3.
Immunohistochemical examination of tissue from a patient with dermatofibrosarcoma protuberans of the breast (200x). (A) Strong and diffuse staining for CD34 indicating spindle cell proliferation. (B) The index of Ki-67 proliferative activity was 10% positive. (C) Focal weak staining for smooth muscle actin and (D) irregular weak/middle staining for CD10. CD, cluster of differentiation.
Figure 4.
Figure 4.
Detection of chromosomal translocation t(17;22)(q22;q13) in paraffin-embedded tissue from a patient with dermatofibrosarcoma protuberans of the breast using gene-specific probes by FISH. (A) COL1A1 and (B) PDGFB break-apart probes: Interphase nuclei with yellow signals indicate an intact COL1A1 (PDGFB) locus. Orange signals denote additional copies of an unbalanced rearranged COL1A1 (PDGFB) locus. (C) COL1A1/PDGFB dual fusion probe: FISH detects separate orange and green normal signals, and multiple yellow (orange/green) fusion signals indicate COL1A1/PDGFB translocation. PDGFB, platelet derived growth factor subunit B; COL1A1, collagen type I α 1 chain; FISH, fluorescence in situ hybridization.

References

    1. Lemm D, Mügge LO, Mentzel T, Höffken K. Current treatment options in dermatofibrosarcoma protuberans. J Cancer Res Clin Oncol. 2009;135:653–665. doi: 10.1007/s00432-009-0550-3. - DOI - PMC - PubMed
    1. Jiang J, Huang Z, Wang LH, Shen SD, Lu H. Dermatofibrosarcoma protuberans of the breast: A case report. Oncol Lett. 2014;8:1202–1204. - PMC - PubMed
    1. Sin FN, Wong KW. Dermatofibrosarcoma protuberans of the breast: A case report. Clin Imaging. 2011;35:398–400. doi: 10.1016/j.clinimag.2011.04.004. - DOI - PubMed
    1. Criscione VD, Weinstock MA. Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002. J Am Acad Dermatol. 2007;56:968–973. doi: 10.1016/j.jaad.2006.09.006. - DOI - PubMed
    1. Llombart B, Serra-Guillén C, Monteagudo C, López Guerrero JA, Sanmartín O. Dermatofibrosarcoma protuberans: A comprehensive review and update on diagnosis and management. Semin Diagn Pathol. 2013;30:13–28. doi: 10.1053/j.semdp.2012.01.002. - DOI - PubMed